Cargando…
The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to b...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520254/ https://www.ncbi.nlm.nih.gov/pubmed/36187112 http://dx.doi.org/10.3389/fendo.2022.981487 |
_version_ | 1784799582318755840 |
---|---|
author | Ali, Dalia Tencerova, Michaela Figeac, Florence Kassem, Moustapha Jafari, Abbas |
author_facet | Ali, Dalia Tencerova, Michaela Figeac, Florence Kassem, Moustapha Jafari, Abbas |
author_sort | Ali, Dalia |
collection | PubMed |
description | Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men. |
format | Online Article Text |
id | pubmed-9520254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95202542022-09-30 The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity Ali, Dalia Tencerova, Michaela Figeac, Florence Kassem, Moustapha Jafari, Abbas Front Endocrinol (Lausanne) Endocrinology Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520254/ /pubmed/36187112 http://dx.doi.org/10.3389/fendo.2022.981487 Text en Copyright © 2022 Ali, Tencerova, Figeac, Kassem and Jafari https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Ali, Dalia Tencerova, Michaela Figeac, Florence Kassem, Moustapha Jafari, Abbas The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity |
title | The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity |
title_full | The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity |
title_fullStr | The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity |
title_full_unstemmed | The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity |
title_short | The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity |
title_sort | pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: the mechanisms and roles of increased bone marrow adiposity |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520254/ https://www.ncbi.nlm.nih.gov/pubmed/36187112 http://dx.doi.org/10.3389/fendo.2022.981487 |
work_keys_str_mv | AT alidalia thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT tencerovamichaela thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT figeacflorence thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT kassemmoustapha thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT jafariabbas thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT alidalia pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT tencerovamichaela pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT figeacflorence pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT kassemmoustapha pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity AT jafariabbas pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity |